Gonorrhea

Vaccines for Biodefense and Emerging and Neglected Diseases

Volumn , Issue , 2008, Pages 963-981

  Russell, Michael W ^a   Hook, Edward W ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875407871     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369408-9.00049-4     Document Type: Chapter

References (165)

1. J. Adu-Bobie, P. Lupetti, B. Brunelli, D. Granoff, N. Norais, G. Ferrari, G. Grandi, R. Rappuoli and M. Pizza (2004) GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence. Infect. Immun. 72 1914-1919
2. S. Agarwal, C.A. King, E.K. Klein, D.E. Soper, P.A. Rice, L.M. Wetzler and C.A. Genco (2005) The gonococcal Fur-regulated tbpA and tbpB genes are expressed during natural mucosal gonococcal infection. Infect. Immun. 73 4281-4287
3. D.J. Anderson and J. Pudney (1999) Human male genital tract immunity and experimental models. P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee,(Eds) Mucosal Immunology San Diego: Academic Press 1411-1422
4. J.E. Anderson, M.M. Hobbs, G.D. Biswas and P.F. Sparling (2003) Opposing selective forces for expression of the gonococcal lactoferrin receptor. Mol. Microbiol. 48 1325-1337
5. M.A. Apicella, M. Shero, G.A. Jarvis, J.M. Griffiss, R.E. Mandrell and H. Schneider (1987) Phenotypic variation in epitope expression of the Neisseria gonorrhoeae lipooligosaccharide. Infect. Immun. 55 1755-1761
6. R.J. Arko (1972) Neisseria gonorrhoeae: experimental infection of laboratory animals. Science 177 1200-1201
7. R.J. Arko (1989) Animal models for pathogenic Neisseria species. Clin. Microbiol. Rev. 2(Suppl.), S56-S59
8. R.J. Arko, W.P. Duncan, W.J. Brown, W.L. Peacock and T. Tomizawa (1976) Immunity in infection with Neisseria gonorrhoeae: duration and serological response in the chimpanzee. J. Infect. Dis. 133 441-447
9. H. Bakke, K. Lie, I.L. Haugen, G.E. Korsvold, E.A. Hoiby, L.M. Nass L.M.r., J. Holst, I.S. Aaberge, F. Oftung and B. Haneberg (2001) Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance. Infect. Immun. 69 5010-5015
10. T.G. Benedek (2005) Gonorrhea and the beginnings of clinical research ethics. Perspect. Biol. Med. 48 54-73
11. M.G. Binker, L.I. Cosen-Binker, M.R. Terebiznik, G.V. Mallo, S.E. McCaw, E.-L. Eskelinen, M. Willenborg, J.H. Brumell, P. Saftig, S. Grinstein and S.D. Gray-Owen (2007) Arrested maturation of Neisseria-containing phagosomes in the absence of the lysosome-associated membrane proteins, LAMP-1 and LAMP-2. Cell. Microbiol. 9 2153-2166
12. R. Bjerknes, H.-K. Guttormsen, C.O. Solberg and L.M. Wetzler (1995) Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burst. Infect. Immun. 63 160-167
13. J.R. Black, W.J. Black and J.G. Cannon (1985) Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections. J. Infect. Dis. 151 650-657
14. M. Blake, K.K. Holmes and J. Swanson (1979) Studies on gonococcus infection. XVII. IgA1-cleaving protease in vaginal washings from women with gonorrhea. J. Infect. Dis. 139 89-92
15. K.J. Blanton, G.D. Biswas, J. Tsai, J. Adams, D.W. Dyer, S.M. Davis, G.G. Koch, P.K. Sen and P.F. Sparling (1990) Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J. Bacteriol. 172 5225-5235
16. J.W. Boslego, E.C. Tramont, R.C. Chung, D.G. McChesney, J. Ciak, J.C. Sadoff, M.V. Piziak, J.D. Brown, C.C. Brinton, S.W. Wood and J.R. Bryan (1991) Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine 9 154-162
17. I.C. Boulton and S.D. Gray-Owen (2002) Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4 + T lymphocytes. Nat. Immunol. 3 229-236
18. W.J. Brown, C.T. Lucas and U.S. Kuhn (1972) Gonorrhoea in the chimpanzee. Infection with laboratory-passed gonococci and by natural transmission. Br. J. Vener. Dis. 48 177-178
19. C.L. Burch, R.J. Danaher and D.C. Stein (1997) Antigenic variation in Neisseria gonorrhoeae: Production of multiple lipooligosaccharides. J. Bacteriol. 179 982-986
20. N. Cadieux, M. Plante, C.R. Rioux, J. Hamel, B.R. Brodeur and D. Martin (1999) Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein. Infect. Immun. 67 4955-4959
21. J.G. Cannon, W.J. Black, I. Nachamkin and P.W. Stewart (1984) Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species. Infect. Immun. 43 994-999
22. J.A. Cardinale and V.L. Clark (2000) Expression of AniA, the major anaerobically induced outer membrane protein of Neisseria gonorrhoeae, provides protection against killing by normal human sera. Infect. Immun. 68 4368-4369
23. CDC (2006) Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR 55 1-93
24. CDC (2007) Notifiable Diseases/Deaths in Selected Cities Weekly Information. MMWR 55 1396-1407
25. F.W. Chandler, S.J. Kraus and J.C. Watts (1976) Pathological features of experimental gonococcal infection in mice and guinea pigs. Infect. Immun. 13 909-914
26. V.L. Clark, L.A. Campbell, D.A. Palermo, T.M. Evans and K.W. Klimpel (1987) Induction and repression of outer membrane proteins by anaerobic growth of Neisseria gonorrhoeae. Infect. Immun. 55 1359-1364
27. V.L. Clark, J.S. Knapp, S. Thompson and K.W. Klimpel (1988) Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections. Microb. Pathog. 5 381-390
28. M.S. Cohen and J.G. Cannon (1999) Human experimentation with Neisseria gonorrhoeae: progress and goals. J. Infect. Dis. 179(Suppl. 2), S375-S379
29. M. Comanducci, S. Bambini, D.A. Caugant, M. Mora, B. Brunelli, B. Capecchi, L. Ciucchi, R. Rappuoli and M. Pizza (2004) NadA diversity and carriage in Neisseria meningitidis. Infect. Immun. 72 4217-4223
30. M.D. Cooper, Z.A. McGee, M.H. Mulks, J.M. Koomey and T.L. Hindman (1984) Attachment to and invasion of human fallopian tube mucosa by an IgA1 protease-deficient mutant of Neisseria gonorrhoeae and its wild-type parent. J. Infect. Dis. 150 737-744
31. C.N. Cornelissen, J.E. Anderson, I.C. Boulton and P.F. Sparling (2000) Antigenic and sequence diversity in gonococcal transferrin-binding protein A. Infect. Immun. 68 4725-4735
32. C.N. Cornelissen, J.E. Anderson and P.F. Sparling (1997) Characterization of the diversity and the transferrin-binding domain of gonococcal transferrin-binding protein 2. Infect. Immun. 65 822-828
33. C.N. Cornelissen, M. Kelley, M.M. Hobbs, J.E. Anderson, J.G. Cannon, M.S. Cohen and P.F. Sparling (1998) The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol. Microbiol. 27 611-616
34. C.N. Cornelissen and P.F. Sparling (1994) Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol. Microbiol. 14 843-850
35. A.K. Criss, K.A. Kline and H.S. Seifert (2005) The frequency and rate of pilin antigenic variation in Neisseria gonorrhoeae. Mol. Microbiol. 58 510-519
36. J.L. Edwards and M.A. Apicella (2004) The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin. Microbiol. Rev. 17 965-981
37. C. Elkins, K.B. Barkley, N.H. Carbonetti, A.J. Coimbre and P.F. Sparling (1994) Immunobiology of purified recombinant outer membrane porin protein I of Neisseria gonorrhoeae. Mol. Microbiol. 14 1059-1075
38. C. Elkins, N.H. Carbonetti, V.A. Varela, D. Stirewalt, D.G. Klapper and P.F. Sparling (1992) Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol. Microbiol. 6 2617-2628
39. V. Esquanazi and M.M. Streitfeld (1973) Transformation of lymphocytes in gonorrhea before and after therapy. Infect. Immun. 8 503-509
40. M.M. Estabrook, J.M. Griffiss and G.A. Jarvis (1997) Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect. Immun. 65 4436-4444
41. J.W.H. Eyre and B.H. Stewart (1909) The treatment of gonococcus infections by vaccines. Lancet 174 76-81
42. Feinen, B., Jerse, A.E., Gaffen, S.L. and Russell, M.W. Neisseria gonorrhoeae induces a Th17 response. ASM abstract, 2008
43. M. Fisseha, P. Chen, B. Brandt, T. Kijek, E. Moran and W. Zollinger (2005) Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect. Immun. 73 4070-4080
44. K.T. Forest, S.L. Bernstein, E.D. Getzoff, M. So, G. Tribbick, H.M. Geysen, C.D. Deal and J.A. Tainer (1996) Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies. Infect. Immun. 64 644-652
45. K.K. Fox, J.C. Thomas, D.H. Weiner, R.H. Davis, P.F. Sparling and M.S. Cohen (1999) Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. Am. J. Epidemiol. 149 353-358
46. W.S. Gallichan, R.N. Woolstencroft, T. Guarasci, M.J. McCluskie, H.L. Davis and K.L. Rosenthal (2001) Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J. Immunol. 166 3451-3457
47. M.M. Giuliani, J. Adu-Bobie, M. Comanducci, B. Arico, S. Savino, L. Santini, B. Brunelli, S. Bambini, A. Biolchi, B. Capecchi, E. Cartocci, L. Ciucchi, F. Di Marcello, F. Ferlicca, B. Galli, E. Luzzi, V. Masignani, D. Serruto, D. Veggi, M. Contorni, M. Morandi, A. Bartalesi, V. Cinotti, D. Mannucci, F. Titta, E. Ovidi, J.A. Welsch, D. Granoff, R. Rappuoli and M. Pizza (2006) A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U.S.A. 103 10834-10839
48. L. Greenberg, B.B. Diena, F.A. Ashton, R. Wallace, C.P. Kenny, R. Znamirowski, H. Ferrari and J. Atkinson (1974) Gonococcal vaccine studies in Inuvik. Can. J. Public Health 65 29-33
49. C.R. Gregg, M.A. Melly, C.G. Hellerqvist, J.G. Coniglio and Z.A. McGee (1981) Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa. J. Infect. Dis. 143 432-439
50. R. Grifantini, S. Sebastian, E. Frigimelica, M. Draghi, E. Bartolini, A. Muzzi, R. Rappuoli, G. Grandi and C.A. Genco (2003) Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B. Proc. Natl. Acad. Sci. U.S.A. 100 9542-9547
51. J.M. Griffiss and D.K. Goroff (1983) IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J. Immunol. 130 2882-2885
52. A.S. Grimble and M.B. McIllmurray (1973) Cell-mediated immune response in gonorrhoea. Br. J. Vener. Dis. 49 446-449
53. R.M. Hamadeh, M.M. Estabrook, P. Zhou, G.A. Jarvis and J.M. Griffiss (1995) Anti-gal binds to pili of Neisseria meningitidis: The immunoglobulin A isotype blocks complement-mediated killing. Infect. Immun. 63 4900-4906
54. T.S. Hamrick, J.A. Dempsey, M.S. Cohen and J.G. Cannon (2001) Antigenic variation of gonococcal pilin expression in vivo: analysis of the strain FA1090 pilin repertoire and identification of the pilS gene copies recombining with pilE during experimental human infection. Microbiology 147 839-849
55. J.K. Hansen, K.P. Demick, J.M. Mansfield and K.T. Forest (2007) Conserved regions from Neisseria gonorrhoeae pilin are immunosilent and not immunosuppressive. Infect. Immun. 75 4138-4147
56. K.I. Happel, M. Zheng, E. Young, L.J. Quinton, E. Lockhart, A.J. Ramsay, J.E. Shellito, J.R. Schurr, G.J. Bagby, S. Nelson and J.K. Kolls (2003) Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170 4432-4436
57. C.R. Hauck and T.F. Meyer (1997) The lysosomal/phagosomal membrane protein h-lamp-1 is a target of the IgA1 protease of Neisseria gonorrhoeae. FEBS Lett. 405 86-90
58. J.E. Heckels, J.N. Fletcher and M. Virji (1989) The potential protective effect of immunization with outer-membrane protein I from Neisseria gonorrhoeae. J. Gen. Microbiol. 135 2269-2276
59. S.R. Hedges, M.S. Mayo, L. Kallman, J. Mestecky, E.W. Hook and M.W. Russell (1998) Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae. Infect. Immun. 66 5826-5832
60. S.R. Hedges, M.S. Mayo, J. Mestecky, E.W. Hook and M.W. Russell (1999) Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect. Immun. 67 3937-3946
61. S.R. Hedges, D.A. Sibley, M.S. Mayo, E.W. Hook III and M.W. Russell (1998) Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: Effect of concomitant infections. J. Infect. Dis. 178 742-751
62. F.T. Hegge, P.G. Hitchen, F.E. Aas, H. Kristiansen, C. Lovold, W. Egge-Jacobsen, M. Panico, W.Y. Leong, V. Bull, M. Virji, H.R. Morris, A. Dell and M. Koomey (2004) Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili. Proc. Natl. Acad. Sci. U.S.A. 101 10798-10803
63. E.W. Hook and H.H. Handsfield (1999) Gonococcal infections in the adult. K.K. Holmes, P.F. Sparling, P.-A. Mårdh, S.M. Lemon, W.E. Stamm, P. Piot, J.N. Wasserheit,(Eds) Sexually Transmitted Diseases 3rd Edn. New York: McGraw-Hill 451-466
64. V.C. Hou, G.R. Moe, Z. Raad, T. Wuorimaa and D.M. Granoff (2003) Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies. Infect. Immun. 71 6844-6849
65. L. Hussain and T. Lehner (1995) Comparative investigation of Langerhans’ cells and potential receptors for HIV in oral, genital and rectal epithelia. Immunology 85 475-484
66. C.A. Ison, S.G. Hadfield, C.M. Bellinger, S.G. Dawson and A.A. Glynn (1986) The specificity of serum and local antibodies in female gonorrhoea. Clin. Exp. Immunol. 65 198-205
67. S. Jacobsson, S. Thulin, P. Molling, M. Unemo, M. Comanducci, R. Rappuoli and P. Olcen (2006) Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine 24 2161-2168
68. W.M. Janda and C.A. Gaydos (2007) Neisseria. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.L. Landry, M.A. Pfaller,(Eds) Manual of Clinical Microbiology 9th Edn. Washington, DC: ASM Press 601-620
69. G.A. Jarvis and J.M. Griffiss (1991) Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J. Immunol. 147 1962-1967
70. A.E. Jerse (1999) Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67 5699-5708
71. A.E. Jerse, M.S. Cohen, P.M. Drown, L.G. Whicker, S.F. Isbey, S. Seifert and J.G. Cannon (1994) Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179 911-920
72. A.E. Jerse and R.F. Rest (1997) Adhesion and invasion by the pathogenic Neisseria. Trends Microbiol. 5 217-221
73. H. Källström, M.K. Liszewski, J.P. Atkinson and A.B. Jonsson (1997) Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25 639-647
74. T.H. Kawula, S.M. Spinola, D.G. Klapper and J.G. Cannon (1987) Localization of a conserved epitope and an azurin-like domain in the H.8 protein of pathogenic Neisseria. Mol. Microbiol. 1 179-185
75. D.H. Kearns, R.J. O’Reilly, L. Lee and B.G. Welch (1973) Secretory IgA antibodies in the urethral exudate of men with uncomplicated urethritis due to Neisseria gonorrhoeae. J. Infect. Dis. 127 99-101
76. D.H. Kearns, G.B. Seibert, R. O’Reilly, L. Lee and L. Logan (1973) Paradox of the immune response to uncomplicated gonococcal urethritis. N. Engl. J. Med. 289 1170-1174
77. C. Kemper, A.C. Chan, J.M. Green, K.A. Brett, K.M. Murphy and J.P. Atkinson (2003) Activation of human CD4 + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421 388-392
78. M. Kilian and M.W. Russell (2005) Microbial evasion of IgA functions. J. Mestecky, J. Bienenstock, M.E. Lamm, L. Mayer, W. Strober, J.R. McGhee,(Eds) Mucosal Immunology Amsterdam: Elsevier/Academic Press 291-303
79. S.J. Kraus, G.H. Perkins and R.C. Geller (1970) Lymphocyte transformation in repeated gonococcal urethritis. Infect. Immun. 2 655-658
80. W.H. Kutteh (1999) Mucosal immunity in the human female reproductive tract. P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee,(Eds) Mucosal Immunology San Diego: Academic Press 1423-1434
81. P.J. Landolfo, T.J. Marrie, N.A. Nelson and A.R. Ronald (1981) Cell-mediated immune response in gonococcal infection. Can. J. Microbiol. 27 76-80
82. H.S. Lee, I.C. Boulton, K. Reddin, H. Wong, D. Halliwell, O. Mandelboim, A.R. Gorringe and S.D. Gray-Owen (2007) Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4 + T lymphocyte function. Infect. Immun. 75 4449-4455
83. L. Lin, P. Ayala, J. Larson, M. Mulks, M. Fukuda, S.R. Carlsson, C. Enns and M. So (1997) The Neisseria type 2 IgA1 protease cleaves LAMP1 and promotes survival of bacteria within epithelial cells. Mol. Microbiol. 24 1083-1094
84. H. Lomholt, I. Lind and M. Kilian (1995) Neisseria gonorrhoeae IgA1 proteases share epitopes recognized by neutralizing antibodies. Vaccine 13 1213-1219
85. H. Lomholt, K. Poulsen and M. Kilian (1995) Antigenic and genetic heterogeneity among Haemophilus and Neisseria IgA1 proteases. Adv. Exp. Med. Biol. 371A 599-603
86. G.H. Lowell, W.R. Ballou, L.F. Smith, R.A. Wirtz, W.D. Zollinger and W.T. Hockmeyer (1988) Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides. Science 240 800-802
87. C.T. Lucas, F. Chandler, J.E. Martin and J.D. Schmale (1971) Transfer of gonococcal urethritis from man to chimpanzee. An animal model for gonorrhea. JAMA 216 1612-1614
88. F.G. Mackinnon, Y. Ho, M.S. Blake, F. Michon, A. Chandraker, M.H. Sayegh and L.M. Wetzler (1999) The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin. J. Infect. Dis. 180 755-761
89. R.E. Mandrell, J.M. Griffiss and B.A. Macher (1988) Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. J. Exp. Med. 168 107-126
90. R.E. Mandrell, A.J. Lesse, J.V. Sugai, M. Shero, J.M. Griffiss, J.A. Cole, N.J. Parsons, H. Smith, S.A. Morse and M.A. Apicella (1990) In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J. Exp. Med. 171 1649-1664
91. D. Martin, B.R. Brodeur, J. Hamel, F. Couture, U. De Alwis, Z.R. Lian, S. Martin, D. Andrews and R.W. Ellis (2000) Candidate Neisseria meningitidis NspA vaccine. J. Biotechnol. 83 27-31
92. D. Martin, N. Cadieux, J. Hamel and B.R. Brodeur (1997) Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J. Exp. Med. 185 1173-1183
93. P. Massari, P. Henneke, Y. Ho, E. Latz, D.T. Golenbock and L.M. Wetzler (2002) Cutting edge: immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol. 168 1533-1537
94. P. Massari, S. Ram, H. Macleod and L.M. Wetzler (2003) The role of porins in neisserial pathogenesis and immunity. Trends Microbiol. 11 87-93
95. Y.V. Matsuka, D.A. Dilts, S. Hoiseth and R. Arumugham (1998) Characterization of a subunit structure and stability of the recombinant porin from Neisseria gonorrhoeae. J. Protein Chem. 17 719-728
96. D. McChesney, E.C. Tramont, J.W. Boslego, J. Ciak, J. Sadoff and C.C. Brinton (1982) Genital antibody response to a parenteral gonococcal pilus vaccine. Infect. Immun. 36 1006-1012
97. A. McMillan, G. McNeillage and H. Young (1979) Antibodies to Neisseria gonorrhoeae: a study of the urethral exudates of 232 men. J. Infect. Dis. 140 89-95
98. A. McMillan, G. McNeillage, H. Young and S.S.R. Bain (1979) Secretory antibody response of the cervix to infection with Neisseria gonorrhoeae. Br. J. Vener. Dis. 55 265-270
99. A. McMillan, G. McNeillage, H. Young and S.R. Bain (1979) Serum immunoglobulin response in uncomplicated gonorrhoea. Br. J. Vener. Dis. 55 5-9
100. G.R. Moe, P. Zuno-Mitchell, S.S. Lee, A.H. Lucas and D.M. Granoff (2001) Functional activity of anti-neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B. Infect. Immun. 69 3762-3771
101. M. Naumann, S. Wessler, C. Bartsch, B. Wieland and T.F. Meyer (1997) Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor κB and activator protein 1 and the induction of inflammatory cytokines. J. Exp. Med. 186 247-258
102. R.C. Noble, N.M. Kirk, W.A. Slagel, B.J. Vance and G.W. Somes (1977) Recidivism among patients with gonococcal infection presenting to a venereal disease clinic. Sex. Transm. Dis. 4 39-43
103. W.B. Ober (1970) Boswell’s clap. JAMA 212 91-95
104. R.J. O’Reilly, L. Lee and B.G. Welch (1976) Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. J. Infect. Dis. 133 113-125
105. M. Pantelic, Y.-J. Kim, S. Bolland, I. Chen, J. Shively and T. Chen (2005) Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production. Infect. Immun. 73 4171-4179
106. H.E. Parge, K.T. Forest, M.J. Hickey, D.A. Christensen, E.D. Getzoff and J.A. Tainer (1995) Structure of the fibre-forming protein pilin at 2.6 A resolution. Nature 378 32-38
107. M.S. Pate, S.R. Hedges, D.A. Sibley, M.W. Russell, E.W. Hook and J. Mestecky (2001) Urethral cytokine and immune responses in Chlamydia trachomatis-infected males. Infect. Immun. 69 7178-7181
108. R.W. Peeling, D. Mabey, A. Herring and E.W. Hook (2006) Why do we need quality-assured diagnostic tests for sexually transmitted infections? Nat. Rev. Microbiol. 4 909-921
109. L.J. Plant and A.-B. Jonsson (2006) Type IV pili of Neisseria gonorrhoeae influence the activation of human CD4 + T cells. Infect. Immun. 74 442-448
110. M. Plante, N. Cadieux, C.R. Rioux, J. Hamel, B.R. Brodeur and D. Martin (1999) Antigenic and molecular conservation of the gonococcal NspA protein. Infect. Immun. 67 2855-2861
111. M. Plante, A. Jerse, J. Hamel, F. Couture, C.R. Rioux, B.R. Brodeur and D. Martin (2000) Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae. J. Infect. Dis. 182 848-855
112. F.A. Plummer, J.N. Simonsen, H. Chubb, L. Slaney, J. Kimata, M. Bosire, J.O. Ndinya-Achola and E.N. Ngugi (1989) Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J. Clin. Invest. 83 1472-1476
113. A. Popp, C. Dehio, F. Grunert, T.F. Meyer and S.D. Gray-Owen (1999) Molecular analysis of neisserial Opa protein interactions with the CEA family of receptors: identification of determinants contributing to the differential specificities of binding. Cell. Microbiol. 1 169-181
114. G.A. Price, M.M. Hobbs and C.N. Cornelissen (2004) Immunogenicity of gonococcal transferrin binding proteins during natural infections. Infect. Immun. 72 277-283
115. Price, G.A., Masri, H.P., Russell, M.W. and Cornelissen, C.N. Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice. Vaccine 2007; 25 7247–7260
116. G.A. Price, M.W. Russell and C.N. Cornelissen (2005) Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Infect. Immun. 73 3945-3953
117. S. Ram, J. Ngampasutadol, A.D. Cox, A.M. Blom, L.A. Lewis, F. St. Michael, J. Stupak, S. Gulati and P.A. Rice (2007) Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance. Infect. Immun. 75 4071-4081
118. S. Ram, A.K. Sharma, S.D. Simpson, S. Gulati, D.P. McQuillen, M.K. Pangburn and P.A. Rice (1998) A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187 743-752
119. K.H. Ramsey, H. Schneider, A.S. Cross, J.W. Boslego, D.L. Hoover, T.L. Staley, R.A. Kuschner and C.D. Deal (1995) Inflammatory cytokines produced in response to experimental human gonorrhea. J. Infect. Dis. 172 186-191
120. P.A. Rice, D.P. McQuillen, S. Gulati, D.B. Jani, L.M. Wetzler, M.S. Blake and E.C. Gotschlich (1994) Serum resistance of Neisseria gonorrhoeae. Does it thwart the inflammatory response and facilitate the transmission of infection? Ann. N. Y. Acad. Sci. 730 7-14
121. P.A. Rice, H.E. Vayo, M.R. Tam and M.S. Blake (1986) Immunoglobulin G antibodies directed against protein III block killing of serum resistant Neisseria gonorrhoeae by immune serum. J. Exp. Med. 164 1735-1748
122. R.C. Riley-Vargas, D.B. Gill, C. Kemper, M.K. Liszewski and J.P. Atkinson (2004) CD46: expanding beyond complement regulation. Trends Immunol. 25 496-503
123. C. Ronpirin, A.E. Jerse and C.N. Cornelissen (2001) Gonococcal genes encoding transferrin-binding proteins A and B are arranged in a bicistronic operon but are subject to differential expression. Infect. Immun. 69 6336-6347
124. J.B. Rothbard, R. Fernandez, L. Wang, N.N. Teng and G.K. Schoolnik (1985) Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion. Proc. Natl. Acad. Sci. U.S.A. 82 915-919
125. T. Rudel, I. Scheuerpflug and T.F. Meyer (1995) Neisseria PilC protein identified as type-4 pilus tip-located adhesin. Nature 373 357-359
126. M.W. Russell and M. Kilian (2005) Biological activities of IgA. J. Mestecky, J. Bienenstock, M.E. Lamm, L. Mayer, W. Strober, J.R. McGhee,(Eds) Mucosal Immunology San Diego: Academic Press 267-289
127. M.W. Russell and J. Mestecky (2002) Humoral immune responses to microbial infections in the genital tract. Microbes Infect. 4 667-677
128. M.W. Russell, J. Reinholdt and M. Kilian (1989) Anti-inflammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgG-mediated complement activation. Eur. J. Immunol. 19 2243-2249
129. S.K. Sarafian and J.S. Knapp (1989) Molecular epidemiology of gonorrhea. Clin. Microbiol. Rev. 2(Suppl.), S49-S55
130. H. Sarantis and S.D. Gray-Owen (2007) The specific innate immune receptor CEACAM3 triggers neutrophil bactericidal activities via a Syk kinase-dependent pathway. Cell. Microbiol. 9 2167-2180
131. K.A. Schmidt, H. Schneider, J.A. Lindstrom, J.W. Boslego, R.A. Warren, L. Van de Verg, C.D. Deal, J.B. McClain and J.M. Griffiss (2001) Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers. Sex. Transm. Dis. 28 555-564
132. A.B. Schryvers and I. Stojiljkovic (1999) Iron acquisition systems in the pathogenic Neisseria. Mol. Microbiol. 32 1117-1123
133. E. Segal, E. Billyard, M. So, S. Storzbach and T.F. Meyer (1985) Role of chromosomal rearrangement in N. gonorrhoeae pilus phase variation. Cell 40 293-300
134. H.S. Seifert, C.J. Wright, A.E. Jerse, M.S. Cohen and J.G. Cannon (1994) Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J. Clin. Invest. 93 2744-2749
135. L. Serino, B. Nesta, R. Leuzzi, M.R. Fontana, E. Monaci, B.T. Mocca, E. Cartocci, V. Masignani, A.E. Jerse, R. Rappuoli and M. Pizza (2007) Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization. Mol. Microbiol. 64 1391-1403
136. W.M. Shafer and R.F. Rest (1989) Interactions of gonococci with phagocytic cells. Annu. Rev. Microbiol. 43 121-145
137. M. Siegel, D. Olsen, C. Critchlow and T.M. Buchanan (1982) Gonococcal pili: safety and immunogenicity in humans and antibody function in vitro. J. Infect. Dis. 145 300-310
138. M.P. Simons, W.M. Nauseef and M.A. Apicella (2005) Interactions of Neisseria gonorrhoeae with adherent polymorphonuclear leukocytes. Infect. Immun. 73 1971-1977
139. S.D. Simpson, Y. Ho, P.A. Rice and L.M. Wetzler (1999) T lymphocyte response to Neisseria gonorrhoeae porin in individuals with mucosal gonococcal infections. J. Infect. Dis. 180 762-773
140. T.E. Singleton, P. Massari and L.M. Wetzler (2005) Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J. Immunol. 174 3545-3550
141. H. Smith, N.J. Parsons and J.A. Cole (1995) Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity. Microb. Pathog. 19 365-377
142. P.F. Sparling (1999) Biology of Neisseria gonorrhoeae. K.K. Holmes, P.F. Sparling, P.-A. Mårdh, S.M. Lemon, W.E. Stamm, P. Piot, J.N. Wasserheit,(Eds) Sexually Transmitted Diseases 3rd Edn. New York: McGraw-Hill 433-449
143. J. Swanson, K. Robbins, O. Barrera, D. Corwin, J. Boslego, J. Ciak, M. Blake and J.M. Koomey (1987) Gonococcal pilin variants in experimental gonorrhea. J. Exp. Med. 165 1344-1357
144. P. Tapchaisri and S. Sirisinha (1976) Serum and secretory antibody responses to Neisseria gonorrhoeae in patients with gonococcal infections. Br. J. Vener. Dis. 52 374-380
145. D.M. Tobiason and H.S. Seifert (2001) Inverse relationship between pilus-mediated gonococcal adherence and surface expression of the pilus receptor, CD46. Microbiology 147 2333-2340
146. E.C. Tramont (1977) Inhibition of adherence of Neisseria gonorrhoeae by human genital secretions. J. Clin. Invest. 59 117-124
147. E.C. Tramont (1992) Local gonococcal antibodies. Vaccine Res. 1 287-293
148. E.C. Tramont, J. Ciak, J. Boslego, D.C. McChesney, C.C. Brinton and W. Zollinger (1980) Antigenic specificity of antibodies in vaginal secretions during infection with Neisseria gonorrhoeae. J. Infect. Dis. 142 23-31
149. E.C. Tramont, J.C. Sadoff, J.W. Boslego, J. Ciak, D. McChesney, C.C. Brinton, S. Wood and E. Takafuji (1981) Gonococcal pilus vaccine: studies of antigenicity and inhibition of attachment. J. Clin. Invest. 68 881-888
150. L. Vandeputte-Rutten, M.P. Bos, J. Tommassen and P. Gros (2003) Crystal structure of neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential. J. Biol. Chem. 278 24825-24830
151. M. Virji (2000) The structural basis of CEACAM-receptor targeting by neisserial opa proteins: response. Trends Microbiol. 8 260-261
152. M. Virji, J.N. Fletcher, K. Zak and J.E. Heckels (1987) The potential effect of monoclonal antibodies to gonococcal outer membrane protein IA. J. Gen. Microbiol. 133 2639-2646
153. M. Virji and J.E. Heckels (1985) Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies. Infect. Immun. 49 621-628
154. M. Virji, K. Zak and J.E. Heckels (1986) Monoclonal antibodies to gonococcal outer membrane protein IB: use in investigation of the potential protective effect of antibodies directed against conserved and type-specific epitopes. J. Gen. Microbiol. 132 1621-1629
155. C.T. Weaver, R.D. Hatton, P.R. Mangan and L.E. Harrington (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25 821-852
156. L.M. Wetzler, M.S. Blake, K. Barry and E.C. Gotschlich (1992) Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants. J. Infect. Dis. 166 551-555
157. L.W. Wetzler, Y. Ho and H. Reiser (1996) Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J. Exp. Med. 183 1151-1159
158. WHO (2001) Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva: World Health Organization
159. K.H. Wong, R.J. Arko, W.O. Schalla and F.J. Steurer (1979) Immunological and serological diversity of Neisseria gonorrhoeae: identification of new immunotypes and highly protective strains. Infect. Immun. 23 717-722
160. A.E. Wright and S.R. Douglas (1903) An experimental investigation of the role of the blood fluids in connection with phagocytosis. Proc. R. Soc. 72 357-370
161. H.Y. Wu, S. Abdu, D. Stinson and M.W. Russell (2000) Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect. Immun. 68 5539-5545
162. F.A. Wyle, C. Rowlett and T. Blumenthal (1977) Cell-mediated immune response in gonococcal infections. Br. J. Vener. Dis. 53 353-359
163. Q.L. Yang and E.C. Gotschlich (1996) Variation of gonococcal lipooligosaccharide structure is due to alterations in poly-G tracts in lgt genes encoding glycosyl transferases. J. Exp. Med. 183 323-327
164. M.K. Yost-Daljev and C.N. Cornelissen (2004) Determination of surface-exposed, functional domains of gonococcal transferrin-binding protein A. Infect. Immun. 72 1775-1785
165. J.J. Yu, M.J. Ruddy, G.C. Wong, C. Sfintescu, P.J. Baker, J.B. Smith, R.T. Evans and S.L. Gaffen (2007) An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109 3794-3802